Evgeniia N. Bykonia
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Identification of novel 5' UTR variants for enhanced mRNA translation and vaccine immunogenicity.
Journal: Scientific reports
Published: March 09, 2026
Structural Design of T-Cell Epitope-Based mRNA Vaccine Constructs Determines the Quality of T-Cell Immunity and Protective Efficacy Against SARS-CoV-2 in Mice.
Journal: Vaccines
Published: February 13, 2026
Dual Ionizable Lipids (ALC0315 and SM102) in a Novel Lipid Nanoparticle Formulation Enhance In Vivo Delivery and Time-Dependent Expression of Messenger RNA and Self-Amplifying RNA.
Journal: ChemMedChem
Published: January 28, 2026
Development of an mRNA Vaccine for Tick-Borne Encephalitis: Selection of a Prototype Virus Strain.
Journal: Vaccines
Published: November 29, 2025
Circular mRNA against CleanCap linear mRNA vectors: comprehensive comparison, expression, active and passive immunization.
Journal: Frontiers in immunology
Published: October 29, 2025
Comparison of candidate vaccines against Tick-borne encephalitis based on mRNA, simian adenovirus serotype 25 and a chimeric replication-competent yellow fever vaccine strain
Journal: Voprosy virusologii
Published: October 14, 2025
Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins.
Journal: Vaccines
Published: February 07, 2024
Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response.
Journal: Frontiers in immunology
Published: February 03, 2024
Last Updated: 09/26/2026